Join
Live feed
·
NEWSReleasevia Quantisnow
Impel Pharmaceuticals Inc. logo

On December 1, 2023, Michael Kalb Gave Notice Of His Resignation From His Position As Chief Financial Officer Of Impel Pharmaceuticals With His Last Day To Be December 31, 2023-8K

ByQuantisnow·Wall Street's wire, on your screen.
IMPL· Impel Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMPL (Impel Pharmaceuticals Inc.) and more on Quantisnow.